1.03 USD
↘ 0.02 (1.90%)AT CLOSE (03:59 PM EDT)
XORTX Therapeutics Inc. Common Stock
XRTXNASDAQ • USD
1.03
↘ 0.00 (0.29%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
1.03
↘ 0.00 (0.29%)
Market: CLOSED
XORTX Therapeutics Inc. Common Stock (XRTX) trades at $1.05 per share. Technical indicators currently signal "Strong Sell". Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 29, 2026.
Open?$0.98
High?$1.15
Low?$0.95
Prev. Close?$1.05
Volume?14.3K
Avg. Volume?N/A
VWAP?$1.05
Bid / Ask
Bid?$0.83 × 100
Ask?$1.29 × 100
Spread?$0.46
Midpoint?$1.06
Valuation & Ratios
Market Cap?1.9M
Shares Out?1.8M
Float?1.7M
Float %?96.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?13.55%High
Short Interest?237.0K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume2.8M
Settlement Date2026-10-15